Recombinant human interleukin 17A enhances the anti‐<i>Candida</i> effect of human oral mucosal epithelial cells by inhibiting <i>Candida albicans</i> growth and inducing antimicrobial peptides secretion

Abstract

Recombinant human interleukin 17A may inhibit C albicans from infecting hOMECs by affecting the growth and reproduction of C albicans as well as the formation of hyphae. Besides, rhIL17A might induce hBD-2, S100A8 and LL-37 secretion from hOMECs to strengthen their anti-infective ability.